Hmm... I don't think there's any of that kind of news in the pipeline that is likely to drop before summer. The remainder of the trial still has a couple of months left to run. We already have TGA and CE Mark approvals and won't be in a position to even lodge for FDA until after the Carrick study is complete and the results known.
I think the best we can hope for in the announcement department is some commercial deal made on the basis of the very positive interim results.
Tadpoles don't have fingers to cross so I'll just float here staring vacuously at the weeds.
NTI Price at posting:
21.0¢ Sentiment: Hold Disclosure: Held
